Russian drugmaker Binnopharm Group together with China’s Mabwell announced plans to localize the production of a monoclonal ...

Swiss pharma giant Novartis today posted financial results, showing that fourth-quarter 2025 net sales were $13.3 billion (+1 ...

Belgium’s largest drugmaker UCB today announced three-year data from the BE HEARD trials^ for Bimzelx (bimekizumab) in ...

Danish pharma major Novo Nordisk has announced sales and operating profit growth at constant exchange rates (CER) for 2025 ...

US generics lobby the Association for Accessible Medicines (AAM) has welcomed passage of Q1/Q2 provisions in recent US ...

US pharma major Eli Lilly was trading 9% higher in Wednesday’s early trading after announcing its financial results for the ...

US biotech major Amgen announced financial results for the fourth quarter and full year of 2025 after markets closed on ...

A group of 42 US states and territories has filed a fresh antitrust lawsuit accusing Swiss pharma Novartis (NOVN: VX) and its former generics unit Sandoz (SIX: SDZ) of colluding to fix prices and ...

Market research group DelveInsight suggests the market for TIGIT inhibitors could expand sharply over the next decade, even ...

Japanese drugmaker Astellas Pharma has announced top-line results from the STARLIGHT 2 Phase III pivotal study for ...

Pennsylvania-based Third Arc Bio, a biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, has announced the closing of a ...

The USA’s Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR), in collaboration with VITAL, has opened ...